UPR 4301
Center for Molecular Biophysics, CNRS - Orleans
The Center for Molecular Biophysics (CBM) develops research at the interface of chemistry, biology and physics to study the molecular mechanisms that sustain life or dysfunctions leading to diseases.
News
All news2024, November 8 - Seminar of Sophia MISSOURRY
"Exploring DNA Polymerases in Phages with Hypermodified Genomes: Structural and Functional Insights"
2024, October 21 - Seminar of du Prof. Anna WAWRUSZAK
"GreenCosmIn - green chemistry and biotechnology approaches for the development of nature-based cosmetics"
2024, October 11 - Dr Anton GRANZHAN seminar
"Chemical tools to study AP sites in DNA"
October 4, 2024: Dr Jalila SIMAAN seminar
"Getting inspiration from biology for the development of bioinspired metal catalysts"
Professor Anna Wawruszak, from the Lublin Medical University, guest researcher LE STUDIUM is hosted by CBM from September to November 2024.
Anna Wawruszak has joined the "Skin Biology and Microenvironment" team headed by Catherine Grillon.
A new regulatory mechanism involved in the bacterial response to cold shock
Rho-dependent riboswitches regulate the bacterial response to cold shock.
Contrast agents to combine 1H and 19F MRI
Novel contrast agents that are effective in both proton and fluorine MRI make it possible to combine the information generated by these two techniques and thus improve the quality of the results obtained.
Software is ubiquitous in science, yet overlooked
Software is more than just code. It is time to confront the complexities of icenses, uses, governance, infrastructure and other facets of software in science.
Protein filaments in the regulation of gene expression
The article by Mance et al reveals that several transcription factors in the family called ZBTB form filamentous structures composed of numerous identical molecules arranged in a chain. This discovery challenges traditional conceptions of transcription factors.
A major advance for the use of medical cannabis!
The Centre de Biologie Moléculaire (CBM) works alongside Overseed and Orléans University Hospital on preclinical and clinical research into the therapeutic use of cannabis.